Legal status · Canada
Is Semax with selank and dihexa legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Semax with selank and dihexa is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Semax with selank and dihexa in Canada at a glance
| Classification | Not approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 1 of 3 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Semax with selank and dihexa profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing Semax with selank and dihexa is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What Semax with selank and dihexa is
Three nootropic peptides sold as one cognitive stack. Two are registered medicines in Russia with small domestic trials; the third rests on a paper that was retracted in 2025 after an expression of concern in 2021. The combination has never been tested, and no vial size is standard across sellers.
The pitch is one activating peptide, one calming peptide and one synaptogenic peptide, covering focus, anxiety and long-term plasticity. Each third of that pitch has a different evidentiary problem.
Mechanism: Semax is described as modulating BDNF and trkB expression in rodent hippocampus and as having neuroprotective effects in the Russian clinical literature. Selank is a tuftsin analogue with anxiolytic activity linked to enkephalin metabolism.
Regulatory history: None of the three is approved in the United States. Semax and selank hold registrations in Russia; dihexa has never been approved anywhere and never completed clinical development.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Semax with selank and dihexa at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Semax with selank and dihexa in other countries
Frequently asked questions
Is Semax with selank and dihexa legal in Canada?
No. Semax with selank and dihexa is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Can I buy Semax with selank and dihexa in Canada?
No approved product exists to buy. In Canada Semax with selank and dihexa is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Semax with selank and dihexa Health Canada approved?
No. In Canada Semax with selank and dihexa is classified as "Not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: None of the three is approved in the United States. Semax and selank hold registrations in Russia; dihexa has never been approved anywhere and never completed clinical development.. On the evidence, 1 human study is cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Semax with selank and dihexa live on its compound profile.
Semax with selank and dihexa profileThis page is general information about the regulatory status of Semax with selank and dihexa in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.